Monoclonal Antibodies Targeting Vascular Endothelial Growth Factor

Overview of attention for article published in BioDrugs, August 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (75th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

patent: 3 patents

Readers on

mendeley: 145 Mendeley

Summary Patents

So far, Altmetric has seen 3 patents that reference this research output.

Inhibition of SCUBE2, a novel VEGFR2 co-receptor, suppresses tumor angiogenesis

Grant US-11066466-B2

United States of America

INHIBITION OF SCUBE2, A NOVEL VEGFR2 CO-RECEPTOR, SUPPRESSES TUMOR ANGIOGENESIS

Application WO-2017180530-A1

World Intellectual Property Organisation (WIPO)

Fusion protein for antagonizing angiogenesis inducible factors and uses thereof

Application US-9522949-B2

United States of America